About

Maxine Tran is a leading urological surgeon-researcher whose work centers on advancing minimally invasive treatments for kidney cancer, particularly through robotic-assisted surgery and innovative imaging technologies. Her major contributions include pioneering the Nephron Sparing Treatment (NEST) trial, a landmark feasibility study comparing percutaneous cryoablation to robot-assisted partial nephrectomy for small renal masses, which addresses the critical need for high-level evidence in this area. She has also developed novel tools like pneumatically attachable flexible rails for track-guided ultrasound scanning during partial nephrectomy, enhancing intraoperative tumor margin identification. With over 120 citations across her most-cited papers, Tran’s impact is evident in her work on optimizing surgical outcomes, including studies on early mitomycin C instillation after nephroureterectomy and the safety of robotic surgery in complex cases like horseshoe kidneys. Her notable achievements include advancing semi-autonomous manipulation in laparoscopic surgery and creating interactive 3D reconstructions for pre-operative planning in renal fusion anomalies. Tran’s research bridges engineering and clinical practice, offering tangible improvements in precision, safety, and patient-centered care for kidney cancer treatment.

Research Focus

Key Achievements

7
H-Index
15
Papers
130
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Pneumatically Attachable Flexible Rails for Track-Guided Ultrasound Scanning in Robotic-Assisted Partial Nephrectomy—A Preliminary Design Study
21 citations · 2019
📈 Most Prolific Year: 2019 (3 Papers)
🤝 Key Collaborators: 87
🏛 Institutions: University College London, The Royal Free Hospital, Royal Free London NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago